Actual Medicinal Product (AMP) Leflunomide 10mg tablets (Aspire Pharma Ltd)
Stability Information
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Manufacturer advice available. Max 7 days in MCA.
- Provenance
-
This recommendation is based on the products Arava 10mg tablets (SANOFI) and leflunomide 10mg film-coated tablets (Milpharm Limited).
- Generic
- Leflunomide
- Formulation
- Leflunomide 10mg tablets
-
Leflunomide
-
Leflunomide 10mg tablets
-
Leflunomide 10mg tablets (Aspire Pharma Ltd)
-
-
Arava 10mg tablets (Sanofi)
Leflunomide 100mg tablets